$3.07
3M Ago | 1M Ago | Current | |
Buy | 6 | 6 | 6 |
Outperform | 3 | 3 | 3 |
Hold | 2 | 2 | 2 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
The latest share price target for Arbutus Biopharma Corporation (ABUS) is $4.4, offered by 11 analysts offering 12-month price forecasts.
Arbutus Biopharma Corporation (ABUS) has a maximum of 0.43 upside potential, based on 11 analysts offering 12-month price forecasts.
Based on 11 analysts tracking and researching Arbutus Biopharma Corporation (ABUS), 81.82% have a buy recommendation. Remaining 18.18% have either sell or hold recommendations.
The latest share price of Arbutus Biopharma Corporation (ABUS) is $3.07 as of 22/05/2024.
9 of total 11 analysts offering stock ratings for Arbutus Biopharma Corporation ABUS have recommended buy rating.